Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

BACKGROUND: In breast cancer patients routine thromboprophylaxis is not recommended but individualized risk assessment is encouraged. The incorporation of hypercoagulability biomarkers could increase the sensitivity of risk assessment models (RAM) to identify patients at VTE risk. To this aim we inv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Chaari, Mourad, Ayadi, Ines, Rousseau, Aurelie, Lefkou, Eleftheria, Van Dreden, Patrick, Sidibe, Fatoumata, Ketatni, Hela, Galea, Vassiliki, Khaterchi, Amir, Bouzguenda, Racem, Frikha, Mounir, Ghorbal, Lilia, Daoud, Jamel, Kallel, Choumous, Quinn, Martin, Gligorov, Joseph, Lotz, Jean Pierre, Hatmi, Mohamed, Elalamy, Ismail, Gerotziafas, Grigoris T
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4324665/
https://ncbi.nlm.nih.gov/pubmed/25535397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-991
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados